RENIN

RENIN 분자 정보

영어 이름Renin시판 약물 수4
임상 약물 수3표적 별명REN,Renin,Angiotensinogenase,Angiotensin-Forming Enzyme,Renin Precursor, Renal,HNFJ2,EC:3.4.23.15,EC 3.4.23.15,EC 3.4.23
최고 연구 개발 단계Approved
영어 이름Renin
표적 별명REN,Renin,Angiotensinogenase,Angiotensin-Forming Enzyme,Renin Precursor, Renal,HNFJ2,EC:3.4.23.15,EC 3.4.23.15,EC 3.4.23
시판 약물 수4
임상 약물 수3
최고 연구 개발 단계Approved

RENIN 제품 목록

  • 속성

    Protein (2)

  • 제품 라이브러리

    온라인 (2)

  • Human (1)Mouse (1)

  • 태그

    His Tag (2)

  • 마커

    Unconjugated (2)

제품 번호발현 시스템제품 설명단백질 구조순도특성
REN-H5221
Human
HEK293
Human RENIN Protein, His Tag
REN-M5222
Mouse
HEK293
Mouse RENIN Protein, His Tag
총 수량2
  • 1

RENIN분자 배경

Renin is also known as REN and angiotensinogenase, is a circulating enzyme that participates in the body's renin-angiotensin system (RAS), and plays an essential role in the elevation of arterial blood pressure and increased sodium retention by the kidney. Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. Renin is secreted from kidney cells, which are activated via signaling from the macula densa, which responds to the rate of fluid flow through the distal tubule, by decreases in renal perfusion pressure (through stretch receptors in the vascular wall), and by sympathetic nervous stimulation, mainly through beta-1 receptor activation. Renin can bind to ATP6AP2, which results in a fourfold increase in the conversion of angiotensinogen to angiotensin I over that shown by soluble renin. In addition, renin binding results in phosphorylation of serine and tyrosine residues of ATP6AP2. The level of renin mRNA appears to be modulated by the binding of HADHB, HuR and CP1 to a regulatory region in the 3' UTR. An over-active renin-angiotension system leads to vasoconstriction and retention of sodium and water. These effects lead to hypertension. Therefore, renin inhibitors can be used for the treatment of hypertension.

RENIN분자 별명

REN,FLJ10761,Renin,angiotensinogenase

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
MT-2765MT-2765Phase 3 ClinicalMitsubishi Tanabe Pharma CorpHypertension
상세
SP-20104 (Sarfez Pharmaceuticals)SP-20104Phase 2 Clinical1 A Pharma GmbhGlomerulosclerosis, Focal Segmental
상세
Imarikiren hydrochlorideTAK-272; SCO-272Phase 2 ClinicalTakeda Pharmaceutical Co LtdDiabetic Nephropathies; Hepatic Insufficiency; Hypertension; Renal Insufficiency
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Aliskiren Hemifumarate/Amlodipine Besilate/HydrochlorothiazideApprovedNovartis Pharma AgRasitrio, AmturnideUnited StatesHypertensionnull2010-12-21Essential Hypertension; Hypertension
상세
Sitokiren MalateMT-2765; MT2765; I-001; SPH-3127; I001-A; I001-BApprovedMitsubishi Tanabe Pharma, Shanghai Pharmaceuticals Holding Co Ltd信妥安Mainland ChinaEssential HypertensionShanghai Sine Pharmaceutical Laboratories Co Ltd2025-12-03Colitis, Ulcerative; Diabetic Nephropathies; Essential Hypertension; Hypertension; Kidney Diseases; Psoriasis
상세
Aliskiren HemifumarateCGP-60536; SPP-100; SPP-100B; SPP-100A; CGP-60536BApprovedNovartis Pharma AgSprimeo, Enviage, Tekturna, Riprazo, 锐思力, RasilezUnited StatesHypertensionNoden Pharma Dac2007-03-05Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic macular oedema; Diabetic Nephropathies; Essential Hypertension; Glomerulonephritis, IGA; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Myocardial Infarction; Myocardial Ischemia; Overweight
상세
AliskirenApprovedMainland ChinaEssential HypertensionNovartis Pharma Ag2010-03-26Essential Hypertension
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호